$AEO
AMERICAN EAGLE OUTFITTERS INC

2021 Q3 Form 10-Q Financial Statement

#000156459021046979 Filed on September 02, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $1.194B $883.5M
YoY Change 35.16% -15.12%
Cost Of Revenue $691.8M $618.3M
YoY Change 11.88% -6.08%
Gross Profit $502.4M $265.2M
YoY Change 89.44% -30.68%
Gross Profit Margin 42.07% 30.02%
Selling, General & Admin $293.9M $223.7M
YoY Change 31.39% -11.59%
% of Gross Profit 58.51% 84.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $41.52M $39.90M
YoY Change 4.07% -12.11%
% of Gross Profit 8.26% 15.05%
Operating Expenses $334.4M $223.7M
YoY Change 49.48% -11.59%
Operating Profit $168.0M -$12.24M
YoY Change -1472.85% -114.94%
Interest Expense -$8.921M
YoY Change
% of Operating Profit -5.31%
Other Income/Expense, Net $1.400M $1.600M
YoY Change -12.5% -59.9%
Pretax Income $160.4M -$19.23M
YoY Change -934.31% -122.38%
Income Tax $38.93M -$5.478M
% Of Pretax Income 24.26%
Net Earnings $121.5M -$13.75M
YoY Change -983.59% -121.16%
Net Earnings / Revenue 10.18% -1.56%
Basic Earnings Per Share $0.73
Diluted Earnings Per Share $581.6K -$82.98K
COMMON SHARES
Basic Shares Outstanding 167.5M 166.3M
Diluted Shares Outstanding 208.9M 166.3M

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $824.0M $898.8M
YoY Change -8.32% 183.35%
Cash & Equivalents $774.0M $898.8M
Short-Term Investments $325.8M $494.0M
Other Short-Term Assets $118.7M $155.1M
YoY Change -23.46% 123.17%
Inventory $503.5M $421.2M
Prepaid Expenses
Receivables $155.4M $107.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.602B $1.582B
YoY Change 1.21% 55.13%
LONG-TERM ASSETS
Property, Plant & Equipment $641.4M $659.4M
YoY Change -2.72% -12.56%
Goodwill $16.37M $13.11M
YoY Change 24.79% -11.84%
Intangibles $54.26M
YoY Change
Long-Term Investments
YoY Change
Other Assets $78.18M $63.30M
YoY Change 23.5% 28.07%
Total Long-Term Assets $1.893B $2.046B
YoY Change -7.44% -12.55%
TOTAL ASSETS
Total Short-Term Assets $1.602B $1.582B
Total Long-Term Assets $1.893B $2.046B
Total Assets $3.495B $3.628B
YoY Change -3.67% 8.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $221.5M $295.3M
YoY Change -25.0% -6.84%
Accrued Expenses $465.8M $458.2M
YoY Change 1.66% 24.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $769.2M $840.4M
YoY Change -8.47% 10.05%
LONG-TERM LIABILITIES
Long-Term Debt $331.7M $517.0M
YoY Change -35.84%
Other Long-Term Liabilities $1.119B $19.60M
YoY Change 5605.94% -30.73%
Total Long-Term Liabilities $1.450B $1.790B
YoY Change -18.96% 30.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $769.2M $840.4M
Total Long-Term Liabilities $1.450B $1.790B
Total Liabilities $2.219B $2.630B
YoY Change -15.61% 23.44%
SHAREHOLDERS EQUITY
Retained Earnings $2.058B $1.808B
YoY Change 13.87% -12.68%
Common Stock $633.0M $649.8M
YoY Change -2.58% 13.81%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.379B $1.412B
YoY Change -2.31% 2.6%
Treasury Stock Shares $81.11M $83.48M
Shareholders Equity $1.276B $997.9M
YoY Change
Total Liabilities & Shareholders Equity $3.495B $3.628B
YoY Change -3.66% 8.0%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $121.5M -$13.75M
YoY Change -983.59% -121.16%
Depreciation, Depletion And Amortization $41.52M $39.90M
YoY Change 4.07% -12.11%
Cash From Operating Activities $121.5M $173.5M
YoY Change -29.98% 57.87%
INVESTING ACTIVITIES
Capital Expenditures -$53.20M -$27.70M
YoY Change 92.07% -50.71%
Acquisitions
YoY Change
Other Investing Activities $25.00M $30.00M
YoY Change -16.67% -700.0%
Cash From Investing Activities -$28.20M $2.300M
YoY Change -1326.26% -103.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -35.95M -134.4M
YoY Change -73.25% 55.92%
NET CHANGE
Cash From Operating Activities 121.5M 173.5M
Cash From Investing Activities -28.20M 2.300M
Cash From Financing Activities -35.95M -134.4M
Net Change In Cash 57.33M 41.40M
YoY Change 38.48% -210.11%
FREE CASH FLOW
Cash From Operating Activities $121.5M $173.5M
Capital Expenditures -$53.20M -$27.70M
Free Cash Flow $174.7M $201.2M
YoY Change -13.18% 21.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.003
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.006
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.431
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.487
CY2020Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
22837000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1435202000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1141697000
us-gaap Gross Profit
GrossProfit
293505000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
411908000
CY2020Q3 aeo Cash Dividends Declared And Dividend Equivalents
CashDividendsDeclaredAndDividendEquivalents
41000
CY2021Q3 aeo Equity Portion Of Partial Extinguishment Of Convertible Senior Notes Net Of Tax Values
EquityPortionOfPartialExtinguishmentOfConvertibleSeniorNotesNetOfTaxValues
3018000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
121511000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
916000
CY2021Q3 us-gaap Dividends Common Stock
DividendsCommonStock
30317000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1275531000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1247853000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15354000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
20000000
aeo Share Repurchases Related To Employee Stock Based Compensation Awards Value
ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
5215000
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
68330000
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-379000
us-gaap Net Income Loss
NetIncomeLoss
-270915000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14823000
us-gaap Dividends Common Stock
DividendsCommonStock
22305000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
997900000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1086665000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
21454000
aeo Share Repurchases Related To Employee Stock Based Compensation Awards Value
ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
17511000
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
14313000
aeo Equity Portion Of Partial Extinguishment Of Convertible Senior Notes Net Of Tax Values
EquityPortionOfPartialExtinguishmentOfConvertibleSeniorNotesNetOfTaxValues
3018000
us-gaap Net Income Loss
NetIncomeLoss
216977000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3854000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.3175
us-gaap Dividends Common Stock
DividendsCommonStock
53239000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1275531000
us-gaap Profit Loss
ProfitLoss
-270915000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
83305000
us-gaap Share Based Compensation
ShareBasedCompensation
15654000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5437000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
153617000
us-gaap Increase Decrease In Retail Related Inventories
IncreaseDecreaseInRetailRelatedInventories
-22119000
aeo Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-142564000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-187602000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-70831000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
94433000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8591000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
22797000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-43450000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36419000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61402000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
14956000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
69956000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
372000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6774000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
900000
aeo Property Plant And Equipment Weighted Average Useful Life
PropertyPlantAndEquipmentWeightedAverageUsefulLife
P7Y
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q3 aeo Revenue Related To Gift Card Breakage
RevenueRelatedToGiftCardBreakage
2000000.0
CY2020Q3 aeo Revenue Related To Gift Card Breakage
RevenueRelatedToGiftCardBreakage
1600000
aeo Revenue Related To Gift Card Breakage
RevenueRelatedToGiftCardBreakage
4400000
aeo Revenue Related To Gift Card Breakage
RevenueRelatedToGiftCardBreakage
3300000
CY2021Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
CY2020Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
84100000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
773994000
CY2021Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
850477000
CY2020Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
898787000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
50000000
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
823994000
CY2021Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
850477000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
153600000
CY2021Q3 us-gaap Goodwill Gross
GoodwillGross
20561000
CY2021Q1 us-gaap Goodwill Gross
GoodwillGross
17463000
CY2020Q3 us-gaap Goodwill Gross
GoodwillGross
17310000
CY2021Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
4196000
CY2021Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
4196000
CY2020Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
4196000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
36367000
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
35083000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2330665000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2250974000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2225579000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1689269000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1627166000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1566228000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
641396000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
623808000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
659351000
CY2021Q3 us-gaap Goodwill
Goodwill
16365000
CY2021Q1 us-gaap Goodwill
Goodwill
13267000
CY2020Q3 us-gaap Goodwill
Goodwill
13114000
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
93335000
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
92663000
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
72057000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
39080000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
35598000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33739000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54255000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
57065000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38318000
CY2021Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
70620000
CY2021Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
70332000
CY2020Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
51432000
CY2020 aeo Accumulated Impairment Loss
AccumulatedImpairmentLoss
1700000
CY2017 aeo Accumulated Impairment Loss
AccumulatedImpairmentLoss
2500000
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
331680000
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
325290000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
516953000
CY2021Q3 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
58454000
CY2021Q1 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
68330000
CY2020Q3 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
68330000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
9000000.0
CY2021Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6800000
us-gaap Share Based Compensation
ShareBasedCompensation
21600000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
16400000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
11600000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
7000000.0
us-gaap Share Based Compensation
ShareBasedCompensation
15700000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
9500000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3940000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
449000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
32.58
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
771000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
16.33
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3618000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.76
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
64071000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2778000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
16.50
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
28599000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1788000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.28
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
32531000
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.62
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
21.41
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13100000
aeo Employee Service Share Based Compensation Tax Benefit Expense Realized From Share Based Payments
EmployeeServiceShareBasedCompensationTaxBenefitExpenseRealizedFromShareBasedPayments
4100000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.016
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.507
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y4M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7600000
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.285
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.245
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.288
CY2021Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
600000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1194156000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
167996000
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
49399000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
883510000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12237000
CY2020Q3 aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
14611000
CY2020Q3 aeo Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
2374000
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
27492000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2228769000
us-gaap Operating Income Loss
OperatingIncomeLoss
301424000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
86205000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1435202000
us-gaap Operating Income Loss
OperatingIncomeLoss
-370478000
aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
170231000
aeo Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
-200247000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
61402000
CY2021Q3 aeo Non Operating Interest Expense Net
NonOperatingInterestExpenseNet
8900000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1400000
aeo Non Operating Interest Expense Net
NonOperatingInterestExpenseNet
17400000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3200000
CY2020Q3 aeo Non Operating Interest Expense Net
NonOperatingInterestExpenseNet
8500000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1600000
aeo Non Operating Interest Expense Net
NonOperatingInterestExpenseNet
8700000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1400000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1194156000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
883510000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2228769000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1435202000
CY2021Q3 aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
0
aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
153617000
CY2020Q3 aeo Incremental Corona Virus Disease Two Thousand And Nineteen Related Expenses
IncrementalCoronaVirusDiseaseTwoThousandAndNineteenRelatedExpenses
13885000
aeo Incremental Corona Virus Disease Two Thousand And Nineteen Related Expenses
IncrementalCoronaVirusDiseaseTwoThousandAndNineteenRelatedExpenses
13885000
CY2020Q3 us-gaap Restructuring Costs
RestructuringCosts
726000
us-gaap Restructuring Costs
RestructuringCosts
2729000
CY2020Q3 aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
14611000
aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
170231000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
153600000
CY2021Q1 us-gaap Restructuring Reserve
RestructuringReserve
2812000
aeo Payments For Restructuring And Restructuring Reserve Accrual Adjustment
PaymentsForRestructuringAndRestructuringReserveAccrualAdjustment
1857000
CY2021Q3 us-gaap Restructuring Reserve
RestructuringReserve
955000

Files In Submission

Name View Source Status
0001564590-21-046979-index-headers.html Edgar Link pending
0001564590-21-046979-index.html Edgar Link pending
0001564590-21-046979.txt Edgar Link pending
0001564590-21-046979-xbrl.zip Edgar Link pending
aeo-10q_20210731.htm Edgar Link pending
aeo-10q_20210731_htm.xml Edgar Link completed
aeo-20210731.xsd Edgar Link pending
aeo-20210731_cal.xml Edgar Link unprocessable
aeo-20210731_def.xml Edgar Link unprocessable
aeo-20210731_lab.xml Edgar Link unprocessable
aeo-20210731_pre.xml Edgar Link unprocessable
aeo-ex311_7.htm Edgar Link pending
aeo-ex312_8.htm Edgar Link pending
aeo-ex321_6.htm Edgar Link pending
aeo-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending